"Perceived poor results". This is not an issue of perception but reality. Look at the losses earned for the last 5 years. There is history- the Sept Qtr is not a one off. Look at capex forecasts Vs actuals as well over the years.
KM costs were supposed to be $35/lb at June 2012? Past statements and delivery of promises conveniently forgotten in this case.
The losses are draining cash. If the company spends $450m in FY 2013 and earns $350m this means more cash out the door and an additional interest bill to foot.
PDN is a high cost producer (the big players have a C1 cost < $20/lb). It is hanging on for dear life but exposing itself to spot prices in the current U2O8 cycle with its position on the cost curve is dangerous.
A simple question. At what stage does PDN need to earn a profit? I think we are there now. A $200m loss in FY 2013 is not going to be able to be withstood by the company in my opinion.
- Forums
- ASX - By Stock
- a quick summary
PDN
paladin energy ltd
Add to My Watchlist
1.02%
!
$7.73

"Perceived poor results". This is not an issue of perception but...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.73 |
Change
-0.080(1.02%) |
Mkt cap ! $3.084B |
Open | High | Low | Value | Volume |
$7.76 | $7.85 | $7.63 | $13.09M | 1.689M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 901 | $7.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.73 | 28 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 712 | 7.710 |
5 | 12000 | 7.700 |
1 | 1305 | 7.660 |
1 | 67 | 7.650 |
2 | 5021 | 7.630 |
Price($) | Vol. | No. |
---|---|---|
7.730 | 28 | 1 |
7.750 | 12583 | 2 |
7.780 | 1000 | 1 |
7.800 | 3851 | 1 |
7.810 | 1200 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PDN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online